[{"NetIncomeLoss_1_Q1_USD":-52614000.0,"OperatingLeaseLiability_0_Q1_USD":16871000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":9573000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":91388000.0,"InventoryFinishedGoodsNetOfReserves_0_Q1_USD":12307000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":121000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q1_USD":104400000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-4344000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_1_Q1_USD":20.81,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":-136000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1_Q1_shares":102000.0,"AssetsCurrent_0_Q1_USD":272288000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_1_Q1_USD":44058000.0,"CostOfGoodsAndServicesSold_1_Q1_USD":9207000.0,"SellingAndMarketingExpense_1_Q1_USD":15236000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q1_USD":883000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":4178000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_1_Q1_USD":40500000.0,"InventoryWorkInProcessNetOfReserves_0_Q1_USD":9606000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":4274000.0,"IncreaseDecreaseInOtherAccruedLiabilities_1_Q1_USD":-3515000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_1_Q1_USD":883000.0,"Liabilities_0_Q1_USD":114707000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q1_USD":19.59,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":19849000.0,"ValuationAllowancesAndReservesDeductions_1_Q1_USD":40532000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":-500000.0,"AccountsReceivableNetCurrent_0_Q1_USD":38525000.0,"CommonStockValue_0_Q1_USD":914000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":739000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_1_Q1_shares":148000.0,"IncreaseDecreaseInEmployeeRelatedLiabilities_1_Q1_USD":-3968000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":883000.0,"CostsAndExpenses_1_Q1_USD":72132000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q1_USD":166500000.0,"IncreaseDecreaseInInventories_1_Q1_USD":724000.0,"DebtSecuritiesAvailableForSaleRealizedGainLoss_1_Q1_USD":0.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-52750000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":1164000.0,"OtherAssetsNoncurrent_0_Q1_USD":346000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":59739000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":13790000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q1_USD":106727000.0,"Assets_0_Q1_USD":310932000.0,"ShareBasedCompensation_1_Q1_USD":11486000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":15594000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":-3325000.0,"AssetImpairmentCharges_1_Q1_USD":80000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q1_USD":121000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":11486000.0,"ValuationAllowancesAndReservesBalance_0_Q1_USD":20889000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-41938000.0,"InventoryRawMaterialsNetOfReserves_0_Q1_USD":20716000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q1_USD":4058000.0,"LiabilitiesCurrent_0_Q1_USD":100917000.0,"AccountsPayableCurrent_0_Q1_USD":1689000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":59739000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":24668000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":1100000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":24744000.0,"AdditionalPaidInCapital_0_Q1_USD":1640552000.0,"CashEquivalentsAtCarryingValue_0_Q1_USD":5000000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_1_Q1_shares":70885.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":22704000.0,"AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_1_Q1_USD":114000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-45399000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":38116000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-1445362000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_1_Q1_USD":20018000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":2978000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q1_USD":4379000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":2718000.0,"OperatingIncomeLoss_1_Q1_USD":-52114000.0,"OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale_1_Q1_USD":0.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q1_USD":106727000.0,"InventoryNet_0_Q1_USD":42629000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1_Q1_USD":18.96,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1_Q1_USD":15.86,"LiabilitiesAndStockholdersEquity_0_Q1_USD":310932000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":9629000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":11486000.0,"AmortizationOfDebtDiscountPremium_1_Q1_USD":502000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":3081000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.58,"StockholdersEquity_0_Q1_USD":196225000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":786000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q1_USD":106606000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_1_Q1_USD":-48000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q1_shares":18795000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":2960000.0,"Ticker":"HRTX","CIK":"818033","name":"HERON THERAPEUTICS, INC. \/DE\/","OfficialName":"Heron Therapeutics Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"558709361.0","Country":"United States","Sector":"Consumer Durables","Industry":"Specialty Chemicals","Market":"NASDAQ","SP500":"nan","filed":"20210510"}]